Dr. Michelle Catherine Sabo, MD, PhD

Dr. Sabo practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Sabo's NPI, 1669714614, was assigned on March 17, 2013. Dr. Sabo holds Washington license MD60575476.

Dr. Sabo's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Sabo's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. Dr. Sabo is also affiliated with Harborview Medical Center. The medical group on file is UW Physicians. Dmand AI also links Dr. Sabo to 1 more hospital and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sabo practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Sabo's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Sabo is licensed in Washington.

CMS data shows 25 Medicare services from Dr. Sabo across 1 procedure code in 2024, for 37 Medicare patients. Medicare paid $2,613 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 37 Medicare patients who saw Dr. Sabo in 2024. The largest group is 75 to 84, with 14 patients. 75% of them have high blood pressure, and 68% have high cholesterol. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sabo's median patient age at 52, with 55% women.

In 2024, Dr. Sabo wrote 293 Medicare Part D claims for 17 patients. 73% of them were for generic drugs. CMS names the drug for 197 of them, across 13 drugs with 11 or more claims each, at $179,989 in total drug cost. In 2023, CMS named 124 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Sabo for performance year 2024, reported through an alternative payment model (APM). Dr. Sabo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sabo as offering telehealth.

Dmand AI links 16 papers to Dr. Sabo, published from 2017 to 2025. 2019 was the busiest year, with 4. The most frequent topics are HIV Infections, Kenya and Vagina. Dr. Sabo has published most often in J Infect Dis. Dr. Sabo's most frequent co-authors are Raymond S. McClelland, MD, Jairam R. Lingappa, MD and Sina Aliasgnar Gharib, MD.

CMS Open Payments shows 2 general payments to Dr. Sabo from 2 drug and device companies in 2023. Food and beverage make up the largest share, 100% of the total. Pharming Healthcare, Inc. paid the most, $124.